Möchten Sie immer auf dem neuesten Stand bleiben?

Ottawa , Feb. 21, 2025 (GLOBE NEWSWIRE) -- The U.S. gene therapy market size was valued at USD 3,650 million in 2024 and is expected to surpass around USD 22,230 million by 2034, growing at a...

Ottawa, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The global in vitro diagnostics market size was valued at USD 102.08 billion in 2024 and is expected to hit around USD 133.24 billion by 2034 with a CAGR of...

Ottawa, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The global viral vector and plasmid DNA manufacturing market size was valued at USD 7.19 billion in 2024 and is expected to be worth around USD 46.02...

Ottawa , Feb. 18, 2025 (GLOBE NEWSWIRE) -- The global injectable drug delivery devices market size was valued at USD 519 billion in 2024 and is expected to hit around USD 1,217 billion by 2034, a...

NEW YORK, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by...

NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by...

Incumbent Board has Destroyed Stockholder Value and Imperiled AIM’s Future through Breaches of Fiduciary Duty and Bad Faith Actions Stock Price has Declined by More than 99%, Clinical Strategy has...

Incumbent Board has Destroyed Stockholder Value and Imperiled AIM’s Future through Breaches of Fiduciary Duty and Bad Faith Actions Stock Price has Declined by More than 99%, Clinical Strategy has...

Vote “FOR” All Four Kellner Group Nominees for Urgently Needed Change Incumbent Board has Destroyed Stockholder Value and Imperiled AIM’s Future through Breaches of Fiduciary Duty and Bad...

ISS Notes Need for Significant Board Change at AIM Due to Clinical Failure and Lack of Transparency According to ISS – “There is no question that for shareholders to have any hope of not losing 100...